Pingora Partners’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.2K Buy
35,739
+32,703
+1,077% +$40.9K 0.03% 135
2025
Q4
$3.79K Buy
3,036
+2,000
+193% +$2.72K ﹤0.01% 197
2025
Q3
$1.34K Hold
1,036
﹤0.01% 198
2025
Q2
$2.02K Hold
1,036
﹤0.01% 200
2025
Q1
$2.63K Hold
1,036
﹤0.01% 202
2024
Q4
$2.26K Hold
1,036
﹤0.01% 220
2024
Q3
$3.23K Hold
1,036
﹤0.01% 216
2024
Q2
$3.08K Sell
1,036
-4
-0.4% -$20 ﹤0.01% 225
2024
Q1
$6.35K Buy
1,040
+546
+111% +$3.91K ﹤0.01% 233
2023
Q4
$4.93K Buy
+494
New +$4.01K ﹤0.01% 151

Other funds holding BCDA

Pingora Partners's BCDA Position: Q1 2026 in Review

Pingora Partners increased its BioCardia (BCDA) stake by 1,077% in Q1 2026, buying an estimated $40.9K and bringing the position to 35,739 shares worth $43.2K. The position accounts for 0.03% of the portfolio, ranked #135.

Pingora Partners first reported a position in BCDA in Q4 2023 and has held it in 10 quarters since. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Pingora Partners held 35,739 shares of BioCardia worth $43.2K as of Q1 2026.
  • Pingora Partners bought 32,703 BioCardia shares in Q1 2026, an estimated $40.9K.
  • BioCardia made up 0.03% of Pingora Partners's portfolio in Q1 2026, its #135 holding.
  • Pingora Partners first reported a position in BioCardia in Q4 2023 and has held it in 10 quarters since.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.